Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

LBPH

Longboard Pharmaceuticals Inc

Apr 18 • 04:00PM ET

18.01

Dollar change +1.01
Percentage change 5.94	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO IWO IWC VFMO ITOT VTWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.39	Insider Own	7.78%	Shs Outstand	36.02M	Perf Week	-11.93%
Market Cap	648.72M	Forward P/E	-	EPS next Y	-2.50	Insider Trans	-58.67%	Shs Float	33.22M	Perf Month	-12.57%
Income	-54.42M	PEG	-	EPS next Q	-0.50	Inst Own	54.51%	Short Float	14.90%	Perf Quarter	-23.98%
Sales	0.00M	P/S	-	EPS this Y	17.03%	Inst Trans	-1.48%	Short Ratio	8.28	Perf Half Y	242.40%
Book/sh	1.67	P/B	10.79	EPS next Y	-26.09%	ROA	-89.72%	Short Interest	4.95M	Perf Year	155.82%
Cash/sh	1.35	P/C	13.38	EPS next 5Y	-	ROE	-106.30%	52W Range	3.60 - 28.15	Perf YTD	198.67%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-132.99%	52W High	-36.02%	Beta	1.36
Dividend TTM	-	Quick Ratio	5.14	Sales past 5Y	0.00%	Gross Margin	-	52W Low	400.28%	ATR (14)	1.37
Dividend Ex-Date	-	Current Ratio	5.14	EPS Y/Y TTM	6.58%	Oper. Margin	0.00%	RSI (14)	43.77	Volatility	7.26% 6.29%
Employees	50	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	42.57
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	4.69%	Payout	-	Rel Volume	0.84	Prev Close	17.00
Sales Surprise	-	EPS Surprise	-5.47%	Sales Q/Q	-	Earnings	Mar 12 AMC	Avg Volume	598.17K	Price	18.01
SMA20	-6.86%	SMA50	-10.86%	SMA200	57.05%	Trades		Volume	502,214	Change	5.94%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-16-24	Initiated	Citigroup	Buy	$40
Oct-24-23	Resumed	Cantor Fitzgerald	Overweight	$16 → $35
Apr-27-23	Initiated	B. Riley Securities	Buy	$13
Apr-07-21	Initiated	Evercore ISI	Outperform	$35
Apr-06-21	Initiated	Guggenheim	Buy	$27
Apr-06-21	Initiated	Citigroup	Buy	$37
Apr-06-21	Initiated	Cantor Fitzgerald	Overweight	$32

Apr-03-24 09:00AM	Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 (Business Wire) -8.39%
Apr-02-24 04:00PM	Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire) -6.03%
Mar-14-24 05:31AM	Longboard Pharmaceuticals Inc Reports Full Year 2023 Financial Results (GuruFocus.com) -5.36%
Mar-12-24 04:01PM	Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates (Business Wire)
Mar-01-24 04:01PM	Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
04:30PM	Loading…
Feb-02-24 04:30PM	Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire) -6.34%
Feb-01-24 08:30AM	Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February (Business Wire)
Jan-17-24 05:51AM	Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher (Motley Fool)
Jan-08-24 04:05PM	Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares (Business Wire)
Jan-05-24 08:50AM	Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why (Zacks)
Jan-03-24 09:40PM	Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock (Business Wire) -10.76%
09:19AM	Longboard Pharma (LBPH) Up on Upbeat Data From Epilepsy Study (Zacks)
Jan-02-24 04:37PM	Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally (Investor's Business Daily) +316.25%
04:01PM	Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock (Business Wire)
01:06PM	Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today? (InvestorPlace)
08:00AM	Loading…
08:00AM	Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs) (Business Wire)
Jan-01-24 04:47PM	Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs) (Business Wire)
Nov-29-23 08:30AM	Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy Volunteers (Business Wire)
Nov-24-23 09:35AM	Down -25.05% in 4 Weeks, Here's Why You Should You Buy the Dip in Longboard Pharmaceuticals, Inc. (LBPH) (Zacks)
Nov-21-23 04:00PM	Longboard Pharmaceuticals Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community (Business Wire)
Nov-14-23 05:05PM	FMR LLC Adjusts Stake in Longboard Pharmaceuticals Inc (GuruFocus.com)
Nov-13-23 02:46PM	Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks (Insider Monkey) -5.47%
Nov-08-23 09:55AM	Wall Street Analysts Believe Longboard Pharmaceuticals, Inc. (LBPH) Could Rally 262.45%: Here's is How to Trade (Zacks)
Nov-03-23 04:01PM	Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-02-23 07:16PM	Longboard Pharmaceuticals Inc (LBPH) Reports Q3 2023 Financial Results (GuruFocus.com)
04:01PM	Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results (Business Wire)
Nov-01-23 08:30AM	Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in November (Business Wire)
Oct-05-23 04:05PM	Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023 (Business Wire) +9.61%
Sep-19-23 08:30AM	Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023 (Business Wire)
Aug-31-23 04:00PM	Longboard Pharmaceuticals to Participate in Three Upcoming Investor Conferences (Business Wire)
04:01PM	Loading…
Aug-30-23 04:01PM	Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings (Business Wire) -6.65%
Aug-23-23 08:30AM	Longboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic Encephalopathies (Business Wire)
Aug-10-23 08:49AM	Institutional investors own a significant stake of 39% in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) (Simply Wall St.)
Aug-03-23 04:01PM	Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results (Business Wire)
08:30AM	Longboard Pharmaceuticals to Present at Upcoming Investor Conferences (Business Wire)
Jun-26-23 04:00PM	Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023 (Business Wire)
May-12-23 06:06AM	Will Longboard Pharmaceuticals (NASDAQ:LBPH) Spend Its Cash Wisely? (Simply Wall St.) -11.74%
May-09-23 04:00PM	Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results (Business Wire)
May-01-23 08:50AM	Longboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainable (Zacks) -6.76%
Apr-14-23 08:50AM	Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why (Zacks) +5.74%
Apr-11-23 04:00PM	Longboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference (Business Wire) +6.38%
Apr-07-23 09:55AM	Does Longboard Pharmaceuticals, Inc. (LBPH) Have the Potential to Rally 208.22% as Wall Street Analysts Expect? (Zacks)
Apr-05-23 07:00AM	Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352 (GlobeNewswire)
Mar-07-23 09:55AM	Wall Street Analysts Predict an 184.81% Upside in Longboard Pharmaceuticals, Inc. (LBPH): Here's What You Should Know (Zacks) -5.24%
Mar-06-23 09:48AM	Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Q4 2022 Earnings Call Transcript (Insider Monkey) +6.35%
Mar-02-23 04:01PM	Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives (Business Wire)
Feb-23-23 04:31PM	Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023 (Business Wire)
Feb-10-23 04:01PM	Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock (Business Wire)
Feb-07-23 09:03PM	Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock (Business Wire)
04:13PM	Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock (Business Wire)
Jan-14-23 08:00AM	Hedge funds investors have a lot riding on Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) with 27% ownership (Simply Wall St.)
Dec-05-22 08:30AM	Longboard Pharmaceuticals Announces Positive Topline Data from a Phase 1 Clinical Study Evaluating Central Nervous System Pharmacokinetics and Pharmacodynamics of LP352 in Healthy Volunteers (Business Wire) -8.57%
Nov-29-22 08:30AM	Longboard Pharmaceuticals Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community (Business Wire)
Nov-08-22 08:30AM	Longboard Pharmaceuticals to Present at Guggenheims Healthcare Talks 4th Annual Immunology and Neurology Day (Business Wire) +8.80%
Nov-03-22 08:30AM	Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results (Business Wire) +8.47%
Oct-25-22 09:00AM	Is Longboard Pharmaceuticals (NASDAQ:LBPH) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Sep-29-22 04:01PM	Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference (GlobeNewswire)
Sep-01-22 04:01PM	Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire) +17.31%
Aug-04-22 04:05PM	Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results (GlobeNewswire) +7.60%
Aug-03-22 08:30AM	Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference (GlobeNewswire)
Jun-07-22 08:30AM	Longboard Pharmaceuticals to Present at the JMP Securities 2022 Life Sciences Conference on June 15 (GlobeNewswire)
Jun-01-22 08:30AM	Longboard Pharmaceuticals to Participate in Five Upcoming Epilepsy-Focused Conferences this Summer (GlobeNewswire)
May-18-22 07:07AM	Companies Like Longboard Pharmaceuticals (NASDAQ:LBPH) Are In A Position To Invest In Growth (Simply Wall St.) -5.67%
May-12-22 08:30AM	Longboard Pharmaceuticals to Participate in Upcoming Investor Events (GlobeNewswire)
May-05-22 04:05PM	Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results (GlobeNewswire)
Apr-01-22 08:30AM	Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting (GlobeNewswire)
Mar-23-22 04:01PM	Longboard Pharmaceuticals to Participate in Cantor Fitzgeralds Virtual Rare Orphan Disease Summit (GlobeNewswire) -6.90%
Mar-22-22 04:01PM	Longboard Pharmaceuticals to Participate in Maxim Group 2022 Virtual Growth Conference (GlobeNewswire)
Mar-21-22 04:01PM	Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer (GlobeNewswire) +6.19%
Mar-03-22 04:05PM	Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results (GlobeNewswire) -12.53%
Jan-05-22 08:30AM	Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference (GlobeNewswire) -8.07%
Dec-09-21 07:52AM	We Think Longboard Pharmaceuticals (NASDAQ:LBPH) Can Afford To Drive Business Growth (Simply Wall St.)
Dec-06-21 10:00AM	Longboard Pharmaceuticals, Inc. (LBPH) Could Find Support Soon, Here's Why You Should Buy the Stock Now (Zacks) -9.33%
Nov-17-21 08:30AM	Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller to Board of Directors (GlobeNewswire)
Nov-11-21 08:30AM	Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-04-21 04:05PM	Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results (GlobeNewswire) -5.56%
Nov-02-21 08:30AM	Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel (GlobeNewswire)
Sep-21-21 08:30AM	Longboard Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference on September 28, 2021 (GlobeNewswire)
Sep-10-21 09:47AM	What You Need To Know About Longboard Pharmaceuticals, Inc.'s (NASDAQ:LBPH) Investor Composition (Simply Wall St.)
Sep-08-21 07:00AM	Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Clinical Trial in Healthy Volunteers, Plans to Initiate Phase 1b/2a Clinical Trial (GlobeNewswire)
Aug-31-21 08:30AM	Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences (GlobeNewswire) +5.51%
Aug-09-21 08:30AM	Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results (GlobeNewswire)
Jun-12-21 05:58AM	We're Not Worried About Longboard Pharmaceuticals' (NASDAQ:LBPH) Cash Burn (Simply Wall St.)
May-10-21 04:05PM	Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results (GlobeNewswire)
Mar-11-21 09:44PM	Longboard Pharmaceuticals Announces Pricing of Initial Public Offering (GlobeNewswire)

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ARENA PHARMACEUTICALS INC	Former 10% Owner	Jan 25 '24	Sale	24.25	3,978,540	96,479,595	0	Jan 29 04:37 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LBPH

Longboard Pharmaceuticals Inc

Upgrade your FINVIZ experience